Wikidata

(Q52620370)

English

The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation.

scientific article published on 11 January 2012

In more languages

Statements

title
The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22234341
retrieved
4 May 2018
reference URL
http://europepmc.org/abstract/MED/22234341

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q52620370&oldid=1854504077"